4.790USD+8.37%Mkt Cap: 172.81M USDP/E: —Last update: 2026-06-01
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), an…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap172.81M USD
Enterprise Value154.21M USD
Revenue (TTM)2.29M USD
Gross Profit720.00K USD
Net Income (TTM)-28.62M USD
Revenue/Share0.0900 USD
Last Price4.790 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS6294441000
Valuation
P/E (Trailing)—
P/E (Forward)8.84
PEG—
EV/EBITDA-9.04
EV/Revenue67.25
P/S69.84
P/B-10.70
EPS (TTM)-1.04
EPS (Forward)0.50
52W Range
1.62098% of range4.855
52W High4.855 USD
52W Low1.620 USD
Profitability
Gross Margin58.78%
Oper. Margin-444.57%
EBITDA Margin0.00%
Profit Margin-2336.49%
ROE179.59%
ROA-220.92%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.11M USD
CapEx (TTM)—
FCF Margin-372.53%
FCF Yield-4.94%
Net Debt-5.78M USD
Net Debt/EBITDA0.34
Balance Sheet
Debt/Equity-0.04
Current Ratio0.29
Quick Ratio0.27
Book Value/Sh-0.4130 USD
Cash/Share0.1850 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateApr 2, 2024
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)42.00 USD
Target Range25.00 USD – 49.00 USD
# Analysts4
Ownership
Shares Out.36.23M
Float30.45M
Insiders7.58%
Institutions17.46%
Short Interest
Short Ratio3.7d
Short % Float13.56%
Short % Out.12.89%
Shares Short4.67M
Short (prev mo.)3.25M
Technical
SMA 502.745 (+74.5%)
SMA 2002.545 (+88.2%)
Beta2.02
S&P 52W Chg27.94%
Avg Vol (30d)1.35M
Avg Vol (10d)1.75M
Technical Indicators
RSI (14)77.7
MACD0.3846
MACD Signal0.2536
MACD Hist.+0.1310
BB Upper4.376 USD
BB Middle3.307 USD
BB Lower2.238 USD
BB Width64.65%
ATR (14)0.3061 USD
Vol Ratio (20d)0.70x